Pharming (PHAR) Operating Leases (2019 - 2025)

Pharming's Operating Leases history spans 7 years, with the latest figure at $17.7 million for Q4 2025.

  • Quarterly results put Operating Leases at $17.7 million for Q4 2025, down 34.3% from a year ago — trailing twelve months through Dec 2025 was $17.7 million (down 34.3% YoY), and the annual figure for FY2025 was $17.7 million, down 34.3%.
  • Operating Leases for Q4 2025 was $17.7 million at Pharming, down from $27.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $33.3 million in Q4 2022 to a low of $17.7 million in Q4 2025.
  • The 5-year median for Operating Leases is $27.0 million (2024), against an average of $26.4 million.
  • The sharpest move saw Operating Leases soared 161.24% in 2021, then plummeted 34.3% in 2025.
  • Year by year, Operating Leases stood at $20.9 million in 2021, then surged by 59.56% to $33.3 million in 2022, then dropped by 0.56% to $33.1 million in 2023, then decreased by 18.58% to $27.0 million in 2024, then crashed by 34.3% to $17.7 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $17.7 million, $27.0 million, and $33.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.